On combining antineoplastic drugs with tumor vaccines.
作者信息
Terando Alicia, Mulé James J
机构信息
Department of Surgery, Center for Immunology and Immunotherapy, University of Michigan Medical Center, 1150 West Medical Center Drive, 1520 MSRB 1, Ann Arbor, MI 48109, USA.
出版信息
Cancer Immunol Immunother. 2003 Nov;52(11):680-5. doi: 10.1007/s00262-003-0426-3. Epub 2003 Aug 29.
Abstract
摘要
相似文献
1
On combining antineoplastic drugs with tumor vaccines.关于抗肿瘤药物与肿瘤疫苗的联合应用。
Cancer Immunol Immunother. 2003 Nov;52(11):680-5. doi: 10.1007/s00262-003-0426-3. Epub 2003 Aug 29.
2
Combinations of anticancer drugs and immunotherapy.抗癌药物与免疫疗法的联合应用。
Cancer Immunol Immunother. 2003 Nov;52(11):686-92. doi: 10.1007/s00262-003-0427-2. Epub 2003 Aug 26.
3
Combined modality immunotherapy and chemotherapy: a new perspective.联合模式免疫疗法与化疗：一种新视角。
Cancer Immunol Immunother. 2008 Oct;57(10):1523-9. doi: 10.1007/s00262-008-0531-4. Epub 2008 May 17.
4
Combining cancer vaccines with chemotherapy.将癌症疫苗与化疗相结合。
Expert Opin Pharmacother. 2005 Dec;6(16):2813-20. doi: 10.1517/14656566.6.16.2813.
5
Chemotherapy: friend or foe to cancer vaccines?化疗：癌症疫苗的朋友还是敌人？
Curr Opin Mol Ther. 2001 Feb;3(1):77-84.
6
The potential beneficial effects of drugs on the immune response to vaccination.药物对疫苗免疫反应的潜在有益影响。
Semin Oncol. 2012 Jun;39(3):340-7. doi: 10.1053/j.seminoncol.2012.02.012.
7
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer.将治疗性疫苗与化疗和免疫疗法相结合用于癌症治疗。
Expert Opin Drug Discov. 2021 Jan;16(1):89-99. doi: 10.1080/17460441.2020.1811673. Epub 2020 Aug 31.
8
Drug Delivery for Cancer Immunotherapy and Vaccines.癌症免疫疗法与疫苗的药物递送
Pharm Nanotechnol. 2018;6(4):232-244. doi: 10.2174/2211738506666180918122337.
9
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.联合治疗的转折点：癌症疫苗与放疗、化疗或靶向小分子抑制剂联合治疗。
Semin Oncol. 2012 Jun;39(3):323-39. doi: 10.1053/j.seminoncol.2012.02.006.
10
Enhancing efficacy of therapeutic vaccinations by combination with other modalities.通过与其他方式联合使用来提高治疗性疫苗的疗效。
Vaccine. 2007 Sep 27;25 Suppl 2(Suppl 2):B89-96. doi: 10.1016/j.vaccine.2007.04.091. Epub 2007 Jun 4.
引用本文的文献
1
Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.总淋巴细胞计数低与接受 GM-CSF 分泌胰腺肿瘤疫苗治疗的胰腺腺癌切除术后患者的不良生存相关。
Ann Surg Oncol. 2013 Dec;20 Suppl 3(0 3):S725-30. doi: 10.1245/s10434-013-3262-5. Epub 2013 Sep 18.
2
Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma.B 细胞耗竭型抗 CD20 抗体联合原位树突状细胞疫苗接种治疗晚期淋巴瘤的疗效增强。
Clin Exp Immunol. 2012 Dec;170(3):291-9. doi: 10.1111/j.1365-2249.2012.04658.x.
3
Current perspectives in prostate cancer vaccines.当前前列腺癌疫苗的研究现状。
Anticancer Agents Med Chem. 2009 Dec;9(10):1052-7. doi: 10.2174/187152009789735062.
4
Promising novel immunotherapies and combinations for prostate cancer.前列腺癌有前景的新型免疫疗法及联合疗法。
Future Oncol. 2009 Mar;5(2):187-96. doi: 10.2217/14796694.5.2.187.
5
Cancer vaccines: current directions and perspectives in prostate cancer.癌症疫苗：前列腺癌的当前研究方向与展望
Curr Opin Mol Ther. 2009 Feb;11(1):31-6.
6
Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.肿瘤内树突状细胞与放化疗联合治疗小鼠鳞状细胞癌
J Immunother. 2008 Nov-Dec;31(9):885-95. doi: 10.1097/CJI.0b013e3181880f1e.
7
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.一项关于多西他赛联合疫苗与单纯疫苗治疗转移性去势抵抗性前列腺癌的随机II期研究。
Clin Cancer Res. 2006 Feb 15;12(4):1260-9. doi: 10.1158/1078-0432.CCR-05-2059.
8
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.分泌粒细胞巨噬细胞集落刺激因子（GM-CSF）的肿瘤细胞疫苗的抗肿瘤疗效不会因给予多西他赛而受到抑制。
Cancer Immunol Immunother. 2006 Oct;55(10):1285-93. doi: 10.1007/s00262-005-0116-4. Epub 2006 Jan 12.
9
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.通过稳态T细胞增殖实现的肿瘤免疫：机制方面与临床前景
Springer Semin Immunopathol. 2005 Jun;27(1):75-85. doi: 10.1007/s00281-004-0196-9. Epub 2005 Jan 22.
10
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.IV期黑色素瘤患者使用T细胞肽表位进行免疫治疗的I/II期研究。
Cancer Immunol Immunother. 2005 Mar;54(3):208-18. doi: 10.1007/s00262-004-0587-8. Epub 2004 Sep 21.
本文引用的文献
1
Specific immune tolerance to anaphylactic sensitization (egg albumin) induced in the guinea pig by cyclophosphoramide (Cytoxan).环磷酰胺（癌得星）诱导豚鼠对过敏性致敏（卵清蛋白）产生的特异性免疫耐受。
J Allergy. 1961 Sep-Oct;32:406-8. doi: 10.1016/0021-8707(61)90018-1.
2
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.抗肿瘤淋巴细胞克隆性再增殖后患者的癌症消退与自身免疫
Science. 2002 Oct 25;298(5594):850-4. doi: 10.1126/science.1076514. Epub 2002 Sep 19.
3
Development of antitumor immune responses in reconstituted lymphopenic hosts.重建的淋巴细胞减少宿主中抗肿瘤免疫反应的发展。
Cancer Res. 2002 Jul 15;62(14):3914-9.
4
T cell homeostatic proliferation elicits effective antitumor autoimmunity.T细胞稳态增殖引发有效的抗肿瘤自身免疫。
J Clin Invest. 2002 Jul;110(2):185-92. doi: 10.1172/JCI15175.
5
Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.肿瘤裂解物脉冲树突状细胞可在早期淋巴细胞恢复过程中引发有效的抗肿瘤免疫反应。
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):931-6. doi: 10.1073/pnas.022634999. Epub 2002 Jan 15.
6
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases.用自体、半抗原修饰的黑色素瘤疫苗治疗转移性黑色素瘤：肺转移灶消退。
Int J Cancer. 2001 Nov;94(4):531-9. doi: 10.1002/ijc.1506.abs.
7
8
Chemotherapy: friend or foe to cancer vaccines?化疗：癌症疫苗的朋友还是敌人？
Curr Opin Mol Ther. 2001 Feb;3(1):77-84.
9
The immunological effects of taxanes.紫杉烷类的免疫效应。
Cancer Immunol Immunother. 2000 Jul;49(4-5):181-5. doi: 10.1007/s002620000122.
10
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.HER-2/neu是经耐受处理的HER-2/neu转基因小鼠中的肿瘤排斥靶点。
Cancer Res. 2000 Jul 1;60(13):3569-76.
Zotero 插件